. 2015 Oct-Dec;36(4):229–237. doi: 10.4103/0971-5851.171543
Copyright: © Indian Journal of Medical and Paediatric Oncology
This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
Table 2.
Summarizes ongoing phase III trials with novel agents
